Trends in AIDS and Mortality in HIV-Infected Subjects With Hemophilia From 1985 to 2003
- 15 April 2006
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 41 (5) , 624-631
- https://doi.org/10.1097/01.qai.0000194232.85336.dc
Abstract
To study trends in progression to AIDS, all-cause mortality, and cause-specific mortality (AIDS-related, liver disease, and hemorrhagic complications) over calendar periods with different exposure to highly active antiretroviral therapy (HAART) in a cohort of hemophiliacs in Spain, taking into account the competing risks of the causes of death. Multicenter cohort of HIV-infected hemophiliacs. HIV seroconversion was estimated using mathematic techniques for interval-censored data from 1979 through 1985. Rates of AIDS and cause-specific death were calculated by Poisson regression, allowing for late entry, for the periods 1985 through 1992, 1993 through 1996, 1997 through 2000 (early HAART), and 2001 through 2003 (late HAART), also allowing for competing risks. Of 585 subjects, 44% were younger than 15 years of age, 82% had severe hemophilia, 86% had type A hemophilia, and the median seroconversion date was October 1982. Calendar period and age at HIV seroconversion strongly influenced AIDS and death rates. Compared with 1993 through 1996, decreases of 75% (relative risk [RR] = 0.25, 95% confidence interval [CI]: 0.14 to 0.43) and 72% (RR = 0.28, 95% CI: 0.12 to 0.63) in the RR of AIDS were observed in early and late HAART. For all-cause mortality, 72% (RR = 0.28, 95% CI: 0.18 to 0.42) and 83% (RR = 0.17, 95% CI: 0.09 to 0.33) decreases were observed by 1997 through 2000 and 2001 through 2003. For liver-related deaths, increases were observed in the late-HAART period (RR = 2.80, 95% CI: 0.94 to 8.36) compared with 1993 through 1996, but using competing risks, this RR was substantially reduced (RR = 1.70, 95% CI: 0.57 to 5.04). Major reductions in AIDS and death rates were observed from 1997 to 2003 in hemophiliacs. These survival improvements are largely attributable to decreases in AIDS-related deaths and have been accompanied by increases in liver disease death rates, which are overestimated if competing risks are not taken into account.Keywords
This publication has 28 references indexed in Scilit:
- The impact of HIV on mortality rates in the complete UK haemophilia populationAIDS, 2004
- Progression of HIV infection and mortality by hepatitis C infection in patients with haemophilia over 20 yearsHaemophilia, 2003
- Effects of HIV infection on age and cause of death for persons with hemophilia A in the United StatesAmerican Journal of Hematology, 2001
- Two decades of HIV infection in a cohort of haemophilic individuals: clinical outcomes and response to highly active antiretroviral therapyAIDS, 2000
- Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysisThe Lancet, 2000
- Determinants of Progression of HIV Infection in a Greek Hemophilia Cohort Followed for Up to 16 Years After SeroconversionJAIDS Journal of Acquired Immune Deficiency Syndromes, 1998
- Mortality before and after HIV infection in the complete UK population of haemophiliacsNature, 1995
- Effect of age at seroconversion on the natural AIDS incubation distributionAIDS, 1994
- Progression of HIV disease in a haemophilic cohort followed for 11 years and the effect of treatment.BMJ, 1991
- Mortality and causes of death in Dutch haemophiliacs, 1973–86British Journal of Haematology, 1989